Specialist care gives better rate of survival

March 16, 2005

A better network of care and access involving specialists and family physicians is needed to save the lives of more heart patients, especially rural residents, according to a University of Alberta study.

"We need to find ways to improve timely and appropriate access to specialists and to improve the structuring of collaborative care," said Dr. Paul Armstrong, professor of medicine in the University of Alberta's division of cardiology, and one of the study's authors.

The researchers discovered that patients discharged after their first hospital stay for heart failure had significantly better outcomes if they received regular cardiovascular follow-up visits with a physician. Those who saw both a family practitioner and a specialist had the lowest mortality rates, even with more complicated conditions. Outpatient care involving both a specialist and a family physician was associated with a 66 per cent drop in the risk of one-year mortality.

"Unfortunately, we found that patients who were elderly and living in rural areas had less access to specialty care. We now know that only a minority of heart failure patients are seen in specialty heart failure clinics where it has been shown that outcomes are improved. These clinics tend to be located in specialty academic centres, which can be difficult for rural patients to access," said Dr. Armstrong.

Results from the two-year study, which also included research from the University of Ottawa, were published recently in the Canadian Medical Association Journal.

The population-based study followed 3,136 patients who were newly diagnosed with congestive heart failure and had just been discharged from 128 Alberta hospitals. Of the patients, 34 per cent received no follow-up visits for cardiovascular care, 24 per cent were seen by a family doctor alone, one per cent by a specialist and 42 per cent by both a family physician and a specialist.

The study showed that compared with patients who received no follow-up care, patients who received regular cardiovascular follow-ups with a specialist had 38 per cent fewer visits to the emergency room, only 13 per cent were readmitted to hospital and the one-year mortality rate was lower--22 per cent versus 37 per cent.

Patients who have follow-up care from both specialists and family physicians are in better health because they have more contacts with the medical community, Dr. Armstrong said. "There are more opportunities for deterioration in status to be detected, for medications to be altered, and for therapies to be reinforced.

Congestive heart failure is suffered by up to two per cent of North American adults, and despite advances in treatment and therapy, still holds a poor prognosis; 30 to 50 per cent die within a year.
-end-


University of Alberta

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.